| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 3, 2003
Accepted on November 14, 2003
1 Departments of: Preclinical and Clinical Pharmacology; Anatomy, Histology & Forensic Medicine, Section Histology; University of Florence. V.le G.Pieraccini, 6. I-50139 Florence, Italy.
* To whom correspondence should be addressed. E-mail: daniele.bani{at}unifi.it.
In animal models of inflammation, the pregnancy hormone relaxin was shown to reduce the recruitment of leukocytes, especially neutrophils, in inflamed tissues. The current study was designed to clarify whether relaxin could inhibit activation of isolated human neutrophils and, if so, whether the nitric oxide (NO) biosynthetic pathway was involved, as occurs in other relaxin targets. Human neutrophils were preincubated with 1, 10 and 100 nmol/liter porcine relaxin for 1 h before activation with N-formyl-Met-Leu-Phe (fMLP, 10 µmol/liter) or phorbol-12-myristate-13-acetate (PMA, 0.1 µmol/liter). In selected experiments, the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, 100 µmol/liter) was added to the samples 30 min. before relaxin. In other experiments, chemically inactivated relaxin (10 nmol/liter) was substituted for authentic relaxin. Untreated, non-activated neutrophils were the controls.
Relaxin reduced significantly and in a concentration-dependent fashion the expression of the surface activation marker CD11b, as well as the generation of superoxide anion, the rise of intracellular Ca2+, the release of cytoplasmic granules and the chemotactic migration. These effects of relaxin were blunted by L-NMMA and could not be reproduced by inactivated relaxin. Relaxin also increased neutrophil iNOS expression and NO generation.
This study provides evidence that relaxin inhibits the activation of human neutrophils stimulated by different proinflammatory agents. This novel property of relaxin could be of relevance in toning down maternal neutrophil activation during pregnancy, thereby counteracting the occurrence of pregnancy-related disorders such as pre-eclampsia, which is regarded as an excess maternal inflammatory response to pregnancy.
This article has been cited by other articles:
 |
|
 |
|
  K. Santora, C. Rasa, D. Visco, B. G. Steinetz, and C. A. Bagnell Antiarthritic Effects of Relaxin, in Combination with Estrogen, in Rat Adjuvant-Induced Arthritis J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-Y. Ho, W. Yan, and C. A. Bagnell Relaxin-induced matrix metalloproteinase-9 expression is associated with activation of the NF-{kappa}B pathway in human THP-1 cells J. Leukoc. Biol., May 1, 2007; 81(5): 1303 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-l. Moore, S.-l. Tan, C.-y. Lo, L. Fang, Y.-D. Su, X.-M. Gao, E. A. Woodcock, R. J. Summers, G. W. Tregear, R. A. D. Bathgate, et al. Relaxin Antagonizes Hypertrophy and Apoptosis in Neonatal Rat Cardiomyocytes Endocrinology, April 1, 2007; 148(4): 1582 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Negishi, Y. Li, A. Usas, F. H. Fu, and J. Huard The Effect of Relaxin Treatment on Skeletal Muscle Injuries Am. J. Sports Med., December 1, 2005; 33(12): 1816 - 1824. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
